Pharmaceutical firm Bayer has sold its remaining 30% stake in Agfa-Gevaert to investment bank Goldman Sachs for approximately $187 million (U.S.). Goldman Sachs plans to resell the 42 million shares to financial investors, according to Bayer.
Agfa was a Bayer subsidiary until 1999, when Bayer spun the unit off. Bayer had retained a 30% share in the Mortsel, Belgium-based company as a temporary financial investment, according to Bayer.
By AuntMinnie.com staff writersJune 10, 2002
Related Reading
Agfa unveils standalone Impax workstation, May 10, 2002
Agfa tapped for nine-hospital PACS in Canada, April 17, 2002
Agfa lands enterprise Impax order, April 5, 2002
Agfa, Hologic join forces in digital mammo, April 2, 2002
Agfa lands large Swiss PACS order, March 25, 2002
Copyright © 2002 AuntMinnie.com
